Role of probiotics in CKD

The Chronic Kidney Disease Solution™ By Shelly Manning It is an eBook that includes the most popular methods to care and manage kidney diseases by following the information provided in it. This easily readable eBook covers up various important topics like what is chronic kidney disease, how it is caused, how it can be diagnosed, tissue damages caused by chronic inflammation, how your condition is affected by gut biome, choices for powerful lifestyle and chronic kidney disease with natural tools etc.

Probiotics are live microorganisms that provide health benefits when consumed in adequate amounts. They are commonly used to promote gut health, but emerging research suggests that probiotics may also play a role in managing chronic kidney disease (CKD). As CKD progresses, there is increasing recognition of the impact of the gut microbiome on systemic health, including inflammation, oxidative stress, and uremic toxin buildup. Probiotics may help improve these factors, offering potential benefits for CKD patients.

Potential Mechanisms of Action of Probiotics in CKD:

Gut Microbiome Modulation:
- The gut microbiome is known to play a role in many systemic conditions, including CKD. In CKD, the balance of gut bacteria often becomes disrupted, with an increase in pathogenic bacteria and a decrease in beneficial bacteria. This dysbiosis can contribute to inflammation and the production of uremic toxins that exacerbate kidney dysfunction.
- Probiotics may help restore the balance of gut bacteria by increasing the population of beneficial microbes, such as lactic acid bacteria (e.g., Lactobacillus, Bifidobacterium), and suppressing harmful bacteria that produce uremic toxins.
Reduction of Uremic Toxins:
- In CKD, the kidneys’ ability to excrete waste products like urea, creatinine, and phosphate is impaired. Some of these substances are metabolized by gut bacteria into uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, which can contribute to systemic inflammation and vascular calcification.
- Probiotics have been shown to reduce the production of uremic toxins by altering the gut microbiome and enhancing the metabolism of nitrogenous compounds. For example, certain probiotic strains can reduce the absorption of toxins in the gut, leading to lower levels of uremic toxins in the bloodstream.
Improved Inflammatory Response:
- Chronic inflammation is a hallmark of CKD and contributes to kidney damage, cardiovascular disease, and other complications. Dysbiosis in the gut may promote systemic inflammation through the production of endotoxins and other inflammatory mediators.
- Probiotics can modulate immune responses, potentially reducing inflammation in CKD patients. They may enhance intestinal barrier function, preventing the translocation of harmful bacteria and endotoxins into the bloodstream, which can otherwise trigger systemic inflammation.
Antioxidant Effects:
- CKD is associated with oxidative stress, which contributes to kidney damage and worsens the progression of the disease. Certain probiotics may exert antioxidant effects by scavenging free radicals, thereby reducing oxidative stress.
- The production of short-chain fatty acids (SCFAs) by probiotics, especially butyrate, has been shown to have anti-inflammatory and antioxidant properties, which may help protect kidney function in CKD.
Improvement in Nitrogen Metabolism:
- One of the key concerns in CKD is the build-up of nitrogenous waste (such as urea and creatinine). Probiotics may help by modulating nitrogen metabolism in the gut, potentially lowering blood urea nitrogen (BUN) levels.
- Some studies suggest that probiotics can assist in the breakdown of proteins in the gut, reducing the load of nitrogenous waste products that the kidneys need to filter.
Potential Effects on Blood Pressure:
- Hypertension is a common comorbidity in CKD and contributes to kidney damage. Some studies suggest that certain probiotic strains may have a mild blood pressure-lowering effect, possibly due to improved gut health, reduced inflammation, and changes in the renin-angiotensin system.

Evidence Supporting Probiotics in CKD:

Clinical studies have shown that probiotics can positively influence various aspects of CKD, including uremic toxin levels, inflammatory markers, oxidative stress, and quality of life. Some studies have also suggested that probiotics can improve gut microbiome diversity, which in turn may slow CKD progression.
- A randomized controlled trial (RCT) in hemodialysis patients demonstrated that probiotic supplementation (using strains like Lactobacillus and Bifidobacterium) resulted in significant reductions in serum creatinine, urea levels, and inflammatory markers like C-reactive protein (CRP).
- Another study indicated that probiotic use was associated with a decrease in blood pressure and improvements in lipid profiles in CKD patients, possibly due to modulation of the gut microbiome and reduction of inflammation.
- Probiotics may also be beneficial in patients with diabetic nephropathy, as they can reduce glucose levels, which may help improve kidney function and delay the progression of CKD.

Types of Probiotics in CKD:

Different probiotic strains have varying effects on CKD, and the specific strain or combination of strains used may depend on the desired therapeutic outcome.

Lactobacillus and Bifidobacterium are two of the most studied genera in CKD. These probiotics are often used due to their ability to modulate the immune response, improve gut barrier function, and reduce toxin production.
Saccharomyces boulardii, a type of yeast, has been found to promote gut health by enhancing intestinal barrier function and reducing the production of harmful metabolites, such as ammonia.
Enterococcus faecium and Lactobacillus rhamnosus have also been studied in CKD for their potential to improve gut microbiome balance and reduce inflammatory markers.

Considerations and Safety:

Safety in Immunocompromised Patients:
- CKD patients, especially those on dialysis, may be at higher risk of infections due to a compromised immune system. Therefore, probiotics must be used cautiously, as probiotic-related infections (e.g., bacteremia) have been reported in immunocompromised individuals.
- It is essential to consult with healthcare providers before starting probiotics, especially in severely ill or immunocompromised patients.
Dosing and Formulation:
- The optimal dose and duration of probiotics in CKD are still being explored. Generally, probiotics are given in specific doses ranging from 1 to 10 billion CFUs (colony-forming units) per day, depending on the strain and the clinical goals.
- Probiotics may be administered in capsules, tablets, or liquid formulations, but their efficacy and survivability in the gastrointestinal tract may vary between products.
Monitoring:
- Monitoring the patient’s response to probiotics is important, especially in terms of uremic toxin levels, inflammatory markers, and overall kidney function. Some patients may experience gastrointestinal side effects like bloating or gas, which typically resolve over time.

Conclusion:

The role of probiotics in CKD management is promising, particularly in improving gut health, reducing uremic toxins, modulating inflammation, and potentially improving kidney function. Although the evidence is still emerging, probiotics have the potential to become a complementary treatment for CKD, especially as part of a broader strategy to manage the disease’s complications, such as uremic toxicity, secondary hyperparathyroidism, and cardiovascular disease.

However, more high-quality, large-scale clinical trials are needed to definitively establish the most effective strains, doses, and treatment regimens for CKD patients. Given the potential risks, particularly in immunocompromised patients, probiotics should be used with caution and under the supervision of a healthcare provider.

Wiki Chronic kidney disease